News

Charter Medical Announces Exclusive Global Distribution Agreement with INCELL Corporation

Charter Medical Ltd., a Fenner PLC subsidiary (LSE:FENR), a globally recognized manufacturer of products for the regenerative medicine and bioprocessing industries, announced today that it has established a strategic partnership with INCELL Corporation, an innovative developer and manufacturer of specialty medias and formulated solutions for tissue and cell collection, transport, processing and storage. The partnership will enable both organizations to meet the growing customer demand for more comprehensive solutions in cell culture, cell expansion, and cryopreservation. Mary Pat Moyer, Founder,…

Sartorius Stedim Biotech Launches Chemistry Testing Services

Sartorius Stedim Biotech (SSB) announced the launch of a full range of chemistry testing services. Offered by its subsidiary Sartorius Stedim BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (MAbs). The service platform methods have been developed to ensure rapid sample analysis and reporting for MAbs and biosimilars. This comprehensive range of chemistry testing services complies with the well-established ICH Q6B scientific guidelines for pharmaceuticals for human use, and includes methods to characterize protein structure,…

MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups

MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts. LabCentral is a private, non-profit organization that provides entrepreneurs and innovative life-sciences startups with lab space and resources to nurture the next generation of biotech companies. It comprises approximately 125 scientists and entrepreneurs. MilliporeSigma’s collaboration with LabCentral, like its ongoing Emerging Biotech grant program, gives biotech startups access to process development tools, education programs and training to support their success and…

Celeros Separations LLC Releases New Line of Automatic Piston Discharge Centrifuges for Bioprocessing Industry

Formerly known as Celeros, Inc in Foxborough, MA, Celeros Separations LLC has been acquired by its founder Robert Bret Carr and is now under new ownership and management based in Durham, NC. This change of ownership is effective as of January, 2017. The Celeros family of APD centrifuges, which includes the APD-75, APD-125, APD-250 and APD 125 II, are semicontinuous automatic solids-discharge high-speed tubular bowl centrifuge. The core technology is the unification of three unique features in one package: the…

MilliporeSigma Releases Poloxamer 188 EMPROVE® EXPERT Polymer for Cell Culture Media

The Poloxamer 188 EMPROVE® EXPERT polymer is a surface-active nonionic polymer used in cell culture media as a shear protectant and has become a standard component to cell culture media for production processes. The new polymer increases robustness of mammalian cells to shear from sparging, resulting in increased viability of cells in the bioreactor. For biopharmaceutical manufacturers, MilliporeSigma’s Poloxamer 188 EMPROVE® EXPERT polymer helps to ensure lot-to-lot consistency and reliable performance. The product has been cell culture tested, optimized and…

MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups

MilliporeSigma,announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts. LabCentral is a private, non-profit organization that provides entrepreneurs and innovative life-sciences startups with lab space and resources to nurture the next generation of biotech companies. It comprises approximately 125 scientists and entrepreneurs. MilliporeSigma’s collaboration with LabCentral, like its ongoing Emerging Biotech grant program, gives biotech startups access to process development tools, education programs and training to support their success and strengthen…

Distek, Inc. Releases Model 2500 Select Bathless Dissolution Tester

Distek, Inc., has released the Model 2500 Select – Bathless Dissolution Tester. The patented bathless technology eliminates the water bath and all associated maintenance while heater jackets raise media temperature from ambient to 37°C in less than 15 minutes. Wireless in-shaft temperature sensors continuously monitor and display the in-vessel temperature for each vessel. A brilliant touch screen and unparalleled command of the instrument with electronic tracking of serialized stirring elements, qualification status and due dates and extensive reporting and method…

Enzo Life Sciences Introduces Innovative Ultra-Sensitive Multiplex IHC Kit

Enzo Life Sciences has released a new immunohistochemistry product, MULTIVIEW® PLUS (mouse-HRP/rabbit-AP) IHC Kit (Brown/Green). This non-biotin nanopolymer detection system contains reagents and materials that detect and localize antigens in formalin-fixed paraffin-embedded tissues. The MULTIVIEW PLUS IHC kit optimizes IHC processes by including the entire workflow, from antigen retrieval to visualization. The MULTIVIEW PLUS system can detect multiple antigens on a single tissue sample, while eliminating the traditional two-step method using biotin/avidin conjugates. The high sensitivity, low background reagents are…

Qosina Trading Company Limited and HNG Medical, Inc. Deliver Components in China

Qosina has announced the establishment of a wholly owned China entity (柯思纳), Qosina Trading Company Limited. Located in Shanghai, this office provides customers the benefit of delivering goods manufactured in China directly to their operations in China, reducing or eliminating related logistics and customs expenses.  Along with a local partner for distribution, HNG Medical, Inc., Qosina can serve global customers with their China operations.

April Spotlight

WHO’s Most-Wanted List: Deadliest Bacteria In February, the World Health Organization (WHO) published its first-ever list of “priority pathogens,” a catalogue of 12 families of bacteria that pose the greatest threats to human health. In particular this list highlights the threat of gram-negative bacteria that are resistant to multiple antibiotics. It is intended to guide and promote research and development (R&D) of new antibiotics. “This is a new tool to ensure R&D responds to urgent public health needs,” said Marie-Paule…